- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/04
Total number of patents in this class: 23195
10-year publication summary
|
1484
|
1578
|
1654
|
1781
|
1669
|
1754
|
1936
|
1795
|
1612
|
613
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4789 |
487 |
| F. Hoffmann-La Roche AG | 7847 |
370 |
| Hoffmann-La Roche Inc. | 3726 |
321 |
| Janssen Pharmaceutica N.V. | 3213 |
313 |
| Merck Sharp & Dohme LLC | 3737 |
312 |
| Novartis AG | 10338 |
305 |
| Gilead Sciences, Inc. | 2207 |
302 |
| Incyte Corporation | 1064 |
280 |
| Merck Patent GmbH | 5669 |
270 |
| Boehringer Ingelheim International GmbH | 4494 |
243 |
| Genentech, Inc. | 4090 |
213 |
| Dana-Farber Cancer Institute, Inc. | 2645 |
194 |
| Pfizer Inc. | 3375 |
191 |
| Takeda Pharmaceutical Company Limited | 2718 |
184 |
| AstraZeneca AB | 2830 |
160 |
| Incyte Holdings Corporation | 626 |
151 |
| Abbvie Inc. | 1837 |
128 |
| The Regents of the University of California | 20590 |
117 |
| Amgen Inc. | 4383 |
117 |
| LG Chem, Ltd. | 17883 |
114 |
| Other owners | 18423 |